Status:

COMPLETED

In Situ Caries of Fluoride Toothpastes

Lead Sponsor:

GlaxoSmithKline

Conditions:

Healthy Subjects

Partial Denture Wearers

Eligibility:

All Genders

18-78 years

Phase:

PHASE3

Brief Summary

This study is to evaluate the effect of fluoride dentifrices on enamel with artificial caries lesions in an in situ model.

Detailed Description

Topical fluorides have been proven to be clinically effective in the prevention of dental caries. It is generally agreed that anti-caries effect of fluoride (F) is mainly by decreasing the rate of ena...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Consent: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • Age:Aged between 18 and 78 years.
  • Compliance:Understands and is willing, able and likely to comply with all study procedures and restrictions.
  • General Health:Good general health with (in the opinion of the investigator) no clinically significant and/or relevant abnormalities of medical history or oral examination that could interfere with subject safety during the study period.
  • Diagnosis: Oral - i. Currently living in the Indianapolis area which is a fluoridated community (1 ppm F). ii. Currently wearing a removable mandibular partial denture with sufficient room in the posterior buccal flange area to accommodate two enamel specimens (required dimensions 12 x 7 millimeters (mm). iii. Willing and capable of wearing their removable partial dentures 24 hours per day during each two week treatment period. iv.All restorations in a good state of repair.
  • Salivary Flow:Have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate = 0.2 ml/minute; gum base stimulated whole saliva flow rate = 0.8 ml/minute).
  • Exclusion Criteria
  • Pregnancy:Women who are known to be pregnant or who are intending to become pregnant over the duration of the study. No pregnancy test will be required.
  • Breast-feeding:Women who are breast-feeding.
  • Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
  • Clinical Study/Experimental Medication:Participation in another clinical study or receipt of an investigational drug within 30 days of the first treatment visit, with the exception of study T3157495 where the wash in period prior to treatment is sufficient.
  • Antibiotics:Currently taking antibiotics or have taken antibiotics in the 2 weeks prior to the screening visit.
  • Fluoride:Taking fluoride supplements for medical reasons.
  • Dental Health: Current active caries or periodontal disease that may compromise the study or health of the subjects.
  • Personnel: a) A member of the site study staff, b) An employee of the sponsor, c) Any employee of any toothpaste manufacturer or their spouse or family member.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2008

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT00708123

    Start Date

    November 1 2007

    End Date

    April 1 2008

    Last Update

    April 22 2013

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.